Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

PPD nets $1.5bn in IPO

Executive Summary

PPD Inc., a PE-owned contract research organization (CRO), netted $1.5B in its initial public offering of 60M shares at $27, the high end of its anticipated $24-27 range.
Deal Industry
  • Biotechnology
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register